EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 117 filers reported holding EPIZYME INC in Q3 2021. The put-call ratio across all filers is 1.61 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $299,000 | +26.2% | 203,200 | -1.3% | 0.00% | – |
| Q1 2022 | $237,000 | -54.0% | 205,831 | 0.0% | 0.00% | – |
| Q4 2021 | $515,000 | -51.1% | 205,831 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $1,053,000 | -38.5% | 205,831 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,711,000 | -4.6% | 205,831 | 0.0% | 0.00% | -66.7% |
| Q1 2021 | $1,793,000 | -20.2% | 205,831 | -0.5% | 0.00% | 0.0% |
| Q4 2020 | $2,247,000 | -9.0% | 206,880 | 0.0% | 0.00% | -25.0% |
| Q3 2020 | $2,468,000 | -25.7% | 206,880 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $3,322,000 | +3.2% | 206,880 | -0.3% | 0.01% | -14.3% |
| Q1 2020 | $3,220,000 | -35.6% | 207,591 | +2.2% | 0.01% | 0.0% |
| Q4 2019 | $4,999,000 | +138.5% | 203,200 | 0.0% | 0.01% | +75.0% |
| Q3 2019 | $2,096,000 | -72.6% | 203,200 | -66.7% | 0.00% | 0.0% |
| Q2 2019 | $7,650,000 | +203.8% | 609,600 | +200.0% | 0.00% | 0.0% |
| Q1 2019 | $2,518,000 | +101.1% | 203,200 | 0.0% | 0.00% | +100.0% |
| Q4 2018 | $1,252,000 | -41.9% | 203,200 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $2,154,000 | -34.8% | 203,200 | -16.7% | 0.00% | -33.3% |
| Q2 2018 | $3,304,000 | -23.1% | 243,861 | +0.7% | 0.01% | -25.0% |
| Q1 2018 | $4,298,000 | +315.3% | 242,121 | +193.5% | 0.01% | +300.0% |
| Q4 2017 | $1,035,000 | +32.2% | 82,485 | +100.7% | 0.00% | +100.0% |
| Q3 2017 | $783,000 | +159.3% | 41,100 | +105.5% | 0.00% | 0.0% |
| Q2 2017 | $302,000 | -12.0% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $343,000 | +41.7% | 20,000 | 0.0% | 0.00% | – |
| Q4 2016 | $242,000 | +22.8% | 20,000 | 0.0% | 0.00% | – |
| Q3 2016 | $197,000 | -52.0% | 20,000 | -50.0% | 0.00% | – |
| Q2 2016 | $410,000 | +69.4% | 40,000 | +100.0% | 0.00% | – |
| Q1 2016 | $242,000 | -24.4% | 20,000 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $320,000 | +24.5% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $257,000 | -46.5% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $480,000 | +27.7% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $376,000 | -0.3% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $377,000 | -30.4% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $542,000 | -12.9% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $622,000 | +36.7% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $455,000 | +9.4% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $416,000 | -48.2% | 20,000 | 0.0% | 0.00% | -50.0% |
| Q3 2013 | $803,000 | +42.6% | 20,000 | 0.0% | 0.00% | +100.0% |
| Q2 2013 | $563,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
| Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
| Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
| MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
| Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
| Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
| Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
| Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
| Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
| Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |